LENZ Therapeutics, Inc.
LENZ
$38.63
-$1.06-2.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -52.40M | -47.74M | -49.77M | -60.81M | -69.47M |
| Total Depreciation and Amortization | 90.00K | 89.00K | 58.00K | 37.00K | 31.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.51M | 3.20M | 3.41M | 2.93M | 2.17M |
| Change in Net Operating Assets | 578.00K | -7.05M | -13.09M | -13.44M | -6.52M |
| Cash from Operations | -47.22M | -51.50M | -59.39M | -71.28M | -73.79M |
| Capital Expenditure | -685.00K | -578.00K | -468.00K | -319.00K | -133.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -54.93M | -153.01M | -154.01M | -127.12M | -83.00M |
| Cash from Investing | -55.61M | -153.59M | -154.48M | -127.44M | -83.13M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 56.42M | 29.93M | 83.70M | 83.65M | 53.82M |
| Repurchase of Common Stock | -- | -150.00K | -150.00K | -150.00K | -150.00K |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -13.00K | -2.00M | 115.45M | 113.54M | 112.99M |
| Cash from Financing | 56.40M | 27.78M | 199.00M | 197.04M | 166.65M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -46.43M | -177.32M | -14.87M | -1.69M | 9.73M |